Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-041094
Filing Date
2021-06-16
Accepted
2021-06-16 19:12:40
Documents
2
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5110
2 EX-24 DOCUMENT attachment1.htm EX-24 3362
  Complete submission text file 0001209191-21-041094.txt   9851
Mailing Address 60 WEST 66TH STREET, 26A NEW YORK NY 10023
Business Address
Bishop Hans Edgar (Reporting) CIK: 0001480212 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40502 | Film No.: 211022834

Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations